These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 28576869

  • 1. Triiodothyroacetic acid in health and disease.
    Groeneweg S, Peeters RP, Visser TJ, Visser WE.
    J Endocrinol; 2017 Aug; 234(2):R99-R121. PubMed ID: 28576869
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic applications of thyroid hormone analogues in resistance to thyroid hormone (RTH) syndromes.
    Groeneweg S, Peeters RP, Visser TJ, Visser WE.
    Mol Cell Endocrinol; 2017 Dec 15; 458():82-90. PubMed ID: 28235578
    [Abstract] [Full Text] [Related]

  • 3. In vitro and mouse studies supporting therapeutic utility of triiodothyroacetic acid in MCT8 deficiency.
    Kersseboom S, Horn S, Visser WE, Chen J, Friesema EC, Vaurs-Barrière C, Peeters RP, Heuer H, Visser TJ.
    Mol Endocrinol; 2014 Dec 15; 28(12):1961-70. PubMed ID: 25389909
    [Abstract] [Full Text] [Related]

  • 4. Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone.
    Takeda T, Suzuki S, Liu RT, DeGroot LJ.
    J Clin Endocrinol Metab; 1995 Jul 15; 80(7):2033-40. PubMed ID: 7608251
    [Abstract] [Full Text] [Related]

  • 5. In vitro effect of Triac on resistance to thyroid hormone receptor mutants: potential basis for therapy.
    Messier N, Laflamme L, Hamann G, Langlois MF.
    Mol Cell Endocrinol; 2001 Mar 28; 174(1-2):59-69. PubMed ID: 11306172
    [Abstract] [Full Text] [Related]

  • 6. Triac regulation of transcription is T(3) receptor isoform- and response element-specific.
    Messier N, Langlois MF.
    Mol Cell Endocrinol; 2000 Jul 25; 165(1-2):57-66. PubMed ID: 10940484
    [Abstract] [Full Text] [Related]

  • 7. Metabolic effects of thyroid hormone derivatives.
    Moreno M, de Lange P, Lombardi A, Silvestri E, Lanni A, Goglia F.
    Thyroid; 2008 Feb 25; 18(2):239-53. PubMed ID: 18279024
    [Abstract] [Full Text] [Related]

  • 8. Evolution of ligands, receptors and metabolizing enzymes of thyroid signaling.
    Holzer G, Roux N, Laudet V.
    Mol Cell Endocrinol; 2017 Dec 25; 459():5-13. PubMed ID: 28342854
    [Abstract] [Full Text] [Related]

  • 9. Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance.
    Radetti G, Persani L, Molinaro G, Mannavola D, Cortelazzi D, Chatterjee VK, Beck-Peccoz P.
    Thyroid; 1997 Oct 25; 7(5):775-8. PubMed ID: 9349583
    [Abstract] [Full Text] [Related]

  • 10. Long-term 3,5,3'-triiodothyroacetic acid therapy in a child with hyperthyroidism caused by thyroid hormone resistance: pharmacological study and therapeutic recommendations.
    Anzai R, Adachi M, Sho N, Muroya K, Asakura Y, Onigata K.
    Thyroid; 2012 Oct 25; 22(10):1069-75. PubMed ID: 22947347
    [Abstract] [Full Text] [Related]

  • 11. Endocrine and neuropsychological assessment in a child with a novel mutation of thyroid hormone receptor: response to 12-month triiodothyroacetic acid (TRIAC) therapy.
    Torre P, Bertoli M, Di Giovanni S, Scommegna S, Conte C, Novelli G, Cianfarani S.
    J Endocrinol Invest; 2005 Oct 25; 28(7):657-62. PubMed ID: 16218051
    [Abstract] [Full Text] [Related]

  • 12. Intracerebroventricular administration of the thyroid hormone analog TRIAC increases its brain content in the absence of MCT8.
    Bárez-López S, Grijota-Martínez C, Liao XH, Refetoff S, Guadaño-Ferraz A.
    PLoS One; 2019 Oct 25; 14(12):e0226017. PubMed ID: 31809508
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the metabolism and distribution of L-triiodothyronine and triiodothyroacetic acid in the rat: a possible explanation of differential hormonal potency.
    Goslings B, Schwartz HL, Dillmann W, Surks MI, Oppenheimer JH.
    Endocrinology; 1976 Mar 25; 98(3):666-75. PubMed ID: 177267
    [Abstract] [Full Text] [Related]

  • 14. Thermogenic effect of triiodothyroacetic acid at low doses in rat adipose tissue without adverse side effects in the thyroid axis.
    Medina-Gomez G, Calvo RM, Obregon MJ.
    Am J Physiol Endocrinol Metab; 2008 Apr 25; 294(4):E688-97. PubMed ID: 18285526
    [Abstract] [Full Text] [Related]

  • 15. Triiodothyroacetic Acid Cross-Reacts With Measurement of Triiodothyronine (T3) on Various Immunoassay Platforms.
    Chan SL, Refetoff S, Babic N, Jin M, Garg U, Yeo KJ.
    Am J Clin Pathol; 2022 Feb 03; 157(2):156-158. PubMed ID: 34542585
    [Abstract] [Full Text] [Related]

  • 16. A novel point mutation in cluster 3 of the thyroid hormone receptor beta gene (P247L) causing mild resistance to thyroid hormone.
    Pohlenz J, Manders L, Sadow PM, Kansal PC, Refetoff S, Weiss RE.
    Thyroid; 1999 Dec 03; 9(12):1195-203. PubMed ID: 10646658
    [Abstract] [Full Text] [Related]

  • 17. Rapid glucuronidation of tri- and tetraiodothyroacetic acid to ester glucuronides in human liver and to ether glucuronides in rat liver.
    Moreno M, Kaptein E, Goglia F, Visser TJ.
    Endocrinology; 1994 Sep 03; 135(3):1004-9. PubMed ID: 8070342
    [Abstract] [Full Text] [Related]

  • 18. Differences in response of thyrotropin to 3,5,3'-triiodothyronine and 3,5,3'-triiodothyroacetic acid in patients with resistance to thyroid hormone.
    Ueda S, Takamatsu J, Fukata S, Tanaka K, Shimizu N, Sakata S, Yamaji T, Kuma K, Ohsawa N.
    Thyroid; 1996 Dec 03; 6(6):563-70. PubMed ID: 9001190
    [Abstract] [Full Text] [Related]

  • 19. Active metabolism of thyroid hormone during metamorphosis of amphioxus.
    Paris M, Hillenweck A, Bertrand S, Delous G, Escriva H, Zalko D, Cravedi JP, Laudet V.
    Integr Comp Biol; 2010 Jul 03; 50(1):63-74. PubMed ID: 21558188
    [Abstract] [Full Text] [Related]

  • 20. The hypothalamus-pituitary-thyroid axis in critical illness.
    Mebis L, van den Berghe G.
    Neth J Med; 2009 Nov 03; 67(10):332-40. PubMed ID: 19915227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.